Prion Disease Flashcards
Definition
Protein-only infectious agent
Rare transmissable spongiform encephalopathies in humans and animals resulting in rapid neurodegeneration
Currently untreatble
Protein structure in prion disease
Prion protein gene on Chr 20, predominantly expressed in CNS Normal protein structure PrP Abdnormal Prp(SC) abnormally folds -> beta sheet configuration + protease?radiation resistant. Seed of PrP(SC) acts as a template which promotes irreversible conversion to insoluble PrP(SC)
Genetics of prion disease
Codon 129 polymorphism and specific PRNP mutations
Differentials of prion disease
Other neurogenetic conditions
Huntington’s, Spinocerebellar ataxia
CJD Treatment
Symptomatic: Conazepam - mycolonus: (Valproate, Levetiracetam, Piracetam)
Delaying prion conversion: Quinacrine, Pentosan, Tetracycline
EEG: Serial EEG shows triphasic changes MRI: Normal/highlighting basal ganglia CSF: 14-3-3 Protein +ve PNRP: No mutations Genetics: Most cases 129 codon MM Western Blot: Types 1-3 Post Mortem: Spongiform vacuolation, PrP amyloid plaques
Sporadic CJD
EEG: Non-specific slow waves
MRI: Posterior thalamus highlighted T2 (Pulvinar sign)
CSF: 14-3-3 can be normal
PNRP: No mutations
Genetics: All cases 129 codon MM
Western Blot: Type 4T from tonsillar biopsy (100% sens+spec)
Post Mortem: PrPsc 4T detectable in CNS + lymphoreticular tissue, Florid plaques
Variant CJD
PNRP: No mutations
Genetics: Most 129 codon Homozygous (MM or VV)
Western Blot: Types 1-3
Iatrogenic CJD
EEG: Non-specific
MRI: Sometimes high signal in basal ganglia
PNRP: Mutations present and diagnostic
Genetics: 129 codon homozygosity may confer earlier onset
Inherited Prion Disease
Somatic PRNP mutation or Spontaneous conversion of PrPc to PRPsc and subsequent seeding
Rapid, progressive dementia with myoclonus, cortical blindness, akinetic mutism and LMN signs
Mean onset is 45-75 years
Mean survival time 6 months from symptoms
Sporadic CJD (80%)
Exposure to bovine spongiform encephalopathy (BSE)
YOunger age of onset (30)
Mean survival 14 months
Psychiatric symptoms to start (anxiety, paranoia, hallucinations)
Development of neuro symptoms (peripheral sensory, ataxia, myoclonus)
Later - chorea,a taxia, dementia
Acquired Variant CJD
Innoculation with human prions most commonly from surgery
Progressive ataxia initially
Dementia and myoclonus later stages
Speed of progression depends on route of inoculation
CNS inoculation fastest
Acquired Iatrogenic
Exposure to human prions from cannibalistic feasts
Progressive cerebellar syndrome (death within 2 years) following 45 year incubation
Dementia is late or absent
Epidemic was 50s/60s
Acquired Kuru
Autosomal dominant
Develops between 20-60 years, mean survival - 5 years
Dysarthria -> cerebellar ataxia -> dementia
Familial Gerstmann-Straussler-Schneiker Syndrome
Autosomal dominant (50 families)
Insomnia and paranoia -> hallucinations -> weight loss
Mute period
Death 1-18 months after start
Fatal Familial insomnia